Faeth Therapeutics, Inc
FTH
NASDAQ
Biotechnology
$32.34
USD
+3.79 (+13.27%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $737.74M
Volume 364.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
OLMA | Olema Pharmaceuticals Inc | $919.60M | - | - | - | |
DSGN | Design Therapeutics Inc | $900.55M | - | - | - | |
CADL | Candel Therapeutics Inc | $864.59M | - | - | - | |
ANNX | Annexon Inc | $856.08M | - | - | - | |
AURA | Aura Biosciences Inc | $793.34M | - | - | - | |
IMMX | Immix Biopharma Inc | $781.21M | - | - | - | |
RIGL | Rigel Pharmaceuticals Inc | $780.54M | 2.42 | +3.3% | - | |
FTH | Faeth Therapeutics, Inc | $737.74M | - | - | - | |
ACHV | Achieve Life Sciences Inc | $725.46M | - | -89.3% | - |
Top Peer by Growth
Rigel Pharmaceuticals Inc
+3.3% YoY Revenue
Lowest P/E Ratio
Rigel Pharmaceuticals Inc
2.42x P/E
Best 1-Year Return
Immix Biopharma Inc
+394.4% Return